Western blot analysis was used to detect protein expression, revealing that PRSS1 expression in cancer tissues from cisplatin-resistant patients was significantly higher than that in cisplatin-sensitive patients, with a P-value of 0.012 (Figure 5E). The gene discussed is PRSS1; the disease is cancer.